Treatment modality | Frequency |
Neo-Adjuvant Chemotherapy | 98% |
MRM with ALND | 90% |
Toilet Mastectomy | 7% |
Adjuvant Radiotherapy | 95% 5% develop metastatic disease during the course of neu-adjuvant chemo-therapy or after surgery |
Hormonal treatment | 60% |